tetano
Editor, Senior Moderator
Cells
. 2022 Sep 4;11(17):2758.
doi: 10.3390/cells11172758.
Lung Organoids as Model to Study SARS-CoV-2 Infection
Li Peng[SUP] 1 [/SUP], Li Gao[SUP] 1 [/SUP], Xinya Wu[SUP] 1 [/SUP], Yuxin Fan[SUP] 1 [/SUP], Meixiao Liu[SUP] 1 [/SUP], Jingjing Chen[SUP] 1 [/SUP], Jieqin Song[SUP] 1 [/SUP], Jing Kong[SUP] 1 [/SUP], Yan Dong[SUP] 1 [/SUP], Bingxue Li[SUP] 1 [/SUP], Aihua Liu[SUP] 1 2 3 [/SUP], Fukai Bao[SUP] 1 2 3 [/SUP]
Affiliations
Abstract
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic and has severely affected socio-economic conditions and people's life. The lung is the major target organ infected and (seriously) damaged by SARS-CoV-2, so a comprehensive understanding of the virus and the mechanism of infection are the first choices to overcome COVID-19. Recent studies have demonstrated the enormous value of human organoids as platforms for virological research, making them an ideal tool for researching host-pathogen interactions. In this study, the various existing lung organoids and their identification biomarkers and applications are summarized. At the same time, the seven coronaviruses currently capable of infecting humans are outlined. Finally, a detailed summary of existing studies on SARS-CoV-2 using lung organoids is provided and includes pathogenesis, drug development, and precision treatment. This review highlights the value of lung organoids in studying SARS-CoV-2 infection, bringing hope that research will alleviate COVID-19-associated lung infections.
Keywords: COVID-19; SARS-CoV-2; coronavirus; lung; organoid.
. 2022 Sep 4;11(17):2758.
doi: 10.3390/cells11172758.
Lung Organoids as Model to Study SARS-CoV-2 Infection
Li Peng[SUP] 1 [/SUP], Li Gao[SUP] 1 [/SUP], Xinya Wu[SUP] 1 [/SUP], Yuxin Fan[SUP] 1 [/SUP], Meixiao Liu[SUP] 1 [/SUP], Jingjing Chen[SUP] 1 [/SUP], Jieqin Song[SUP] 1 [/SUP], Jing Kong[SUP] 1 [/SUP], Yan Dong[SUP] 1 [/SUP], Bingxue Li[SUP] 1 [/SUP], Aihua Liu[SUP] 1 2 3 [/SUP], Fukai Bao[SUP] 1 2 3 [/SUP]
Affiliations
- PMID: 36078166
- DOI: 10.3390/cells11172758
Abstract
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic and has severely affected socio-economic conditions and people's life. The lung is the major target organ infected and (seriously) damaged by SARS-CoV-2, so a comprehensive understanding of the virus and the mechanism of infection are the first choices to overcome COVID-19. Recent studies have demonstrated the enormous value of human organoids as platforms for virological research, making them an ideal tool for researching host-pathogen interactions. In this study, the various existing lung organoids and their identification biomarkers and applications are summarized. At the same time, the seven coronaviruses currently capable of infecting humans are outlined. Finally, a detailed summary of existing studies on SARS-CoV-2 using lung organoids is provided and includes pathogenesis, drug development, and precision treatment. This review highlights the value of lung organoids in studying SARS-CoV-2 infection, bringing hope that research will alleviate COVID-19-associated lung infections.
Keywords: COVID-19; SARS-CoV-2; coronavirus; lung; organoid.